Welcome to LookChem.com Sign In|Join Free
  • or
3-Des(allylthio)Methyl-3-bromoMethyl Althiazide is a chemical compound that belongs to the class of thiazide diuretics. It is a derivative of the parent compound Althiazide, with modifications in its structure, specifically the removal of the allylthio group and the addition of a bromomethyl group. This alteration in the chemical structure may lead to changes in its pharmacological properties, such as its potency, duration of action, or side effect profile. Thiazide diuretics are commonly used in the treatment of hypertension and edema by increasing the excretion of sodium and water in the urine. The specific effects and applications of 3-Des(allylthio)Methyl-3-bromoMethyl Althiazide would depend on its unique characteristics and how they compare to those of the parent compound.

7181-60-4

Post Buying Request

7181-60-4 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

7181-60-4 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 7181-60-4 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 7,1,8 and 1 respectively; the second part has 2 digits, 6 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 7181-60:
(6*7)+(5*1)+(4*8)+(3*1)+(2*6)+(1*0)=94
94 % 10 = 4
So 7181-60-4 is a valid CAS Registry Number.

7181-60-4Downstream Products

7181-60-4Relevant academic research and scientific papers

Nitric oxide enhancing diuretic compounds, compositions and methods of use

-

Page/Page column 48, (2008/06/13)

The invention describes novel compositions and kits comprising at least one nitric oxide enhancing diuretic compound, or pharmaceutically acceptable salts thereof, and, optionally, at least one nitric oxide enhancing compound and/or at least one therapeutic agent. The invention also provides methods for (a) treating conditions resulting from excessive water and/or electrolyte retention; (b) treating cardiovascular diseases; (c) treating renovascular diseases; (d) treating diabetes; (e) treating diseases resulting from oxidative stress; (f) treating endothelial dysfunctions; (g) treating diseases caused by endothelial dysfunctions; (h) treating cirrhosis; (j) treating pre-eclampsia; (k) treating osteoporosis; (l) treating nephropathy; (m) treating peripheral vascular diseases; (n) treating portal hypertension; (o) treating central nervous system disorders; (p) treating metabolic syndrome; (q) treating sexual dysfunctions; and (r) hyperlipidemia. The nitric oxide enhancing diuretic compounds comprise at least one nitric oxide enhancing group linked to the diuretic compound through one or more sites such as carbon, oxygen and/or nitrogen via a bond or moiety that cannot be hydrolyzed.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 7181-60-4